-
1
-
-
77953679596
-
-
The Korean Society of Infectious Diseases. Seoul: Koonja Publishing Inc
-
The Korean Society of Infectious Diseases. Infectious Disease. Seoul: Koonja Publishing Inc; 2007.
-
(2007)
Infectious, Disease
-
-
-
2
-
-
0037087226
-
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
-
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 730-751
-
-
Hughes, W.T.1
Armstrong, D.2
Bodey, G.P.3
Bow, E.J.4
Brown, A.E.5
Calandra, T.6
Feld, R.7
Pizzo, P.A.8
Rolston, K.V.9
Shenep, J.L.10
Young, L.S.11
-
3
-
-
79959813737
-
-
Fort Washington: National Comprehensive Cancer Network
-
Segal BH, Baden LR, Casper C, Dubberke E, Freifeld AG, Gelfand M, Greene JN, Greer JP. NCCN Clinical Practice Guidelines in Oncology Prevention and Treatment of Cancer-Related Infections (v.2.2009). Fort Washington: National Comprehensive Cancer Network; 2009.
-
(2009)
NCCN Clinical Practice Guidelines in Oncology Prevention and Treatment of Cancer-Related Infections (v.2. 2009).
-
-
Segal, B.H.1
Baden, L.R.2
Casper, C.3
Dubberke, E.4
Freifeld, A.G.5
Gelfand, M.6
Greene, J.N.7
Greer, J.P.8
-
4
-
-
0142062504
-
Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Bertz H, Auner HW, Weissinger F, Salwender HJ, Einsele H, Egerer G, Sandherr M, Schuttrumpf S, Sudhoff T, Maschmeyer G. Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S167-74.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Bertz, H.1
Auner, H.W.2
Weissinger, F.3
Salwender, H.J.4
Einsele, H.5
Egerer, G.6
Sandherr, M.7
Schuttrumpf, S.8
Sudhoff, T.9
Maschmeyer, G.10
-
5
-
-
58149088852
-
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Bohme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R, Hebart H, Heinz W, Junghanss C, Karthaus M, Kruger W, Krug U, Kubin T, Penack O, Reichert D, Reuter S, Silling G, Sudhoff T, Ullmann AJ, Maschmeyer G. Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2009;88:97-110.
-
(2009)
Ann Hematol
, vol.88
, pp. 97-110
-
-
Bohme, A.1
Ruhnke, M.2
Buchheidt, D.3
Cornely, O.A.4
Einsele, H.5
Enzensberger, R.6
Hebart, H.7
Heinz, W.8
Junghanss, C.9
Karthaus, M.10
Kruger, W.11
Krug, U.12
Kubin, T.13
Penack, O.14
Reichert, D.15
Reuter, S.16
Silling, G.17
Sudhoff, T.18
Ullmann, A.J.19
Maschmeyer, G.20
more..
-
6
-
-
0142094087
-
Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Bohme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, Heussel G, Heussel CP, Junghanss C, Kern WK, Kubin T, Maschmeyer G, Sezer O, Silling G, Sudhoff T, Szelenyi Dagger H, Ullmann AJ. Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S133-40.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Bohme, A.1
Ruhnke, M.2
Buchheidt, D.3
Karthaus, M.4
Einsele, H.5
Guth, S.6
Heussel, G.7
Heussel, C.P.8
Junghanss, C.9
Kern, W.K.10
Kubin, T.11
Maschmeyer, G.12
Sezer, O.13
Silling, G.14
Sudhoff, T.15
Szelenyi Dagger, H.16
Ullmann, A.J.17
-
7
-
-
0142125784
-
Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Buchheidt D, Bohme A, Cornely OA, Fatkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern WV, Schiel X, Sezer O, Sudhoff T, Szelenyi H. Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S127-32.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Buchheidt, D.1
Bohme, A.2
Cornely, O.A.3
Fatkenheuer, G.4
Fuhr, H.G.5
Heussel, G.6
Junghanss, C.7
Karthaus, M.8
Kellner, O.9
Kern, W.V.10
Schiel, X.11
Sezer, O.12
Sudhoff, T.13
Szelenyi, H.14
-
8
-
-
0142125774
-
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Cornely OA, Bohme A, Buchheidt D, Glasmacher A, Kahl C, Karthaus M, Kern W, Kruger W, Maschmeyer G, Ritter J, Salwender HJ, Sandherr M, Schiel X, Schuttrumpf S, Sieniawski M, Silling G, Ullmann AJ, Wolf HH. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S186-200.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Cornely, O.A.1
Bohme, A.2
Buchheidt, D.3
Glasmacher, A.4
Kahl, C.5
Karthaus, M.6
Kern, W.7
Kruger, W.8
Maschmeyer, G.9
Ritter, J.10
Salwender, H.J.11
Sandherr, M.12
Schiel, X.13
Schuttrumpf, S.14
Sieniawski, M.15
Silling, G.16
Ullmann, A.J.17
Wolf, H.H.18
-
9
-
-
0142062506
-
Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, Holler E, Beck R, Schwerdfeger R, Schumacher U, Hebart H, Martin H, Kienast J, Ullmann AJ, Maschmeyer G, Krüger W, Niederwieser D, Link H, Schmidt CA, Oettle H, Klingebiel T; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S175-85.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Einsele, H.1
Bertz, H.2
Beyer, J.3
Kiehl, M.G.4
Runde, V.5
Kolb, H.J.6
Holler, E.7
Beck, R.8
Schwerdfeger, R.9
Schumacher, U.10
Hebart, H.11
Martin, H.12
Kienast, J.13
Ullmann, A.J.14
Maschmeyer, G.15
Krüger, W.16
Niederwieser, D.17
Link, H.18
Schmidt, C.A.19
Oettle, H.20
Klingebiel, T.21
more..
-
10
-
-
0142125781
-
Central venous catheter (CVC)-related infections in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Fatkenheuer G, Buchheidt D, Cornely OA, Fuhr HG, Karthaus M, Kisro J, Leithauser M, Salwender H, Sudhoff T, Szelenyi H, Weissinger F. Central venous catheter (CVC)-related infections in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S149-57.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Fatkenheuer, G.1
Buchheidt, D.2
Cornely, O.A.3
Fuhr, H.G.4
Karthaus, M.5
Kisro, J.6
Leithauser, M.7
Salwender, H.8
Sudhoff, T.9
Szelenyi, H.10
Weissinger, F.11
-
11
-
-
0142062516
-
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever. Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)
-
Link H, Bohme A, Cornely OA, Hoffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 2003;82 (Suppl 2):S105-17.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Link, H.1
Bohme, A.2
Cornely, O.A.3
Hoffken, K.4
Kellner, O.5
Kern, W.V.6
Mahlberg, R.7
Maschmeyer, G.8
Nowrousian, M.R.9
Ostermann, H.10
Ruhnke, M.11
Sezer, O.12
Schiel, X.13
Wilhelm, M.14
Auner, H.W.15
-
12
-
-
0142125780
-
Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Ruhnke M, Bohme A, Buchheidt D, Donhuijsen K, Einsele H, Enzensberger R, Glasmacher A, Gumbel H, Heussel CP, Karthaus M, Lambrecht E, Sudhoff T, Szelenyi H. Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82 (Suppl 2):S141-8.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Ruhnke, M.1
Bohme, A.2
Buchheidt, D.3
Donhuijsen, K.4
Einsele, H.5
Enzensberger, R.6
Glasmacher, A.7
Gumbel, H.8
Heussel, C.P.9
Karthaus, M.10
Lambrecht, E.11
Sudhoff, T.12
Szelenyi, H.13
-
13
-
-
33745590151
-
Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)
-
Sandherr M, Einsele H, Hebart H, Kahl C, Kern W, Kiehl M, Massenkeil G, Penack O, Schiel X, Schuettrumpf S, Ullmann AJ, Cornely OA. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 2006;17:1051-9.
-
(2006)
Ann Oncol
, vol.17
, pp. 1051-1059
-
-
Sandherr, M.1
Einsele, H.2
Hebart, H.3
Kahl, C.4
Kern, W.5
Kiehl, M.6
Massenkeil, G.7
Penack, O.8
Schiel, X.9
Schuettrumpf, S.10
Ullmann, A.J.11
Cornely, O.A.12
-
14
-
-
34547546151
-
Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
-
Marchetti O, Cordonnier C, Calandra T. Empirical antifungal therapy in neutropaenic cancer patients with persistent fever. Eur J Cancer Suppl 2007;5:32-42.
-
(2007)
Eur J Cancer Suppl
, vol.5
, pp. 32-42
-
-
Marchetti, O.1
Cordonnier, C.2
Calandra, T.3
-
15
-
-
34547581786
-
Primary antifungal prophylaxis in leukaemia patients
-
Maertens JA, Frere P, Lass-Florl C, Heinz W, Cornely OA. Primary antifungal prophylaxis in leukaemia patients. Eur J Cancer Suppl 2007;5:43-48.
-
(2007)
Eur J Cancer Suppl
, vol.5
, pp. 43-48
-
-
Maertens, J.A.1
Frere, P.2
Lass-Florl, C.3
Heinz, W.4
Cornely, O.A.5
-
16
-
-
34547602924
-
The need for aminoglycosides in combination with β-lactams for high-risk, febrile neutropaenic patients with leukaemia
-
Drgona L, Paul M, Bucaneve G, Calandra T, Menichetti F. The need for aminoglycosides in combination with β-lactams for high-risk, febrile neutropaenic patients with leukaemia. Eur J Cancer Suppl 2007;5:13-22.
-
(2007)
Eur J Cancer Suppl
, vol.5
, pp. 13-22
-
-
Drgona, L.1
Paul, M.2
Bucaneve, G.3
Calandra, T.4
Menichetti, F.5
-
17
-
-
34547549798
-
Empirical use of anti-Gram-positive antibiotics in febrile neutropaenic cancer patients with acute leukaemia
-
Cometta A, Marchetti O, Calandra T. Empirical use of anti-Gram-positive antibiotics in febrile neutropaenic cancer patients with acute leukaemia. Eur J Cancer Suppl 2007;5:23-31.
-
(2007)
Eur J Cancer Suppl
, vol.5
, pp. 23-31
-
-
Cometta, A.1
Marchetti, O.2
Calandra, T.3
-
18
-
-
34547508230
-
Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients
-
Bucaneve G, Castagnola E, Viscoli C, Leibovici L, Menichetti F. Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients. Eur J Cancer Suppl 2007;5:5-12.
-
(2007)
Eur J Cancer Suppl
, vol.5
, pp. 5-12
-
-
Bucaneve, G.1
Castagnola, E.2
Viscoli, C.3
Leibovici, L.4
Menichetti, F.5
-
19
-
-
27744585906
-
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever
-
discussion S133-40
-
Jun HX, Zhixiang S, Chun W, Reksodiputro AH, Ranuhardy D, Tamura K, Matsumoto T, Lee DG, Purushotaman SV, Lim V, Ahmed A, Hussain Y, Chua M, Ong A, Liu CY, Hsueh PR, Lin SF, Liu YC, Suwangool P, Jootar S, Picazo JJ. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. Int J Antimicrob Agents 2005;26 (Suppl 2):S128-32; discussion S133-40.
-
(2005)
Int J Antimicrob Agents
, vol.26
, Issue.SUPPL. 2
-
-
Jun, H.X.1
Zhixiang, S.2
Chun, W.3
Reksodiputro, A.H.4
Ranuhardy, D.5
Tamura, K.6
Matsumoto, T.7
Lee, D.G.8
Purushotaman, S.V.9
Lim, V.10
Ahmed, A.11
Hussain, Y.12
Chua, M.13
Ong, A.14
Liu, C.Y.15
Hsueh, P.R.16
Lin, S.F.17
Liu, Y.C.18
Suwangool, P.19
Jootar, S.20
Picazo, J.J.21
more..
-
20
-
-
3242761288
-
Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey
-
Yoshida M, Ohno R. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey. Clin Infect Dis 2004;39 (Suppl 1):S11-4.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Yoshida, M.1
Ohno, R.2
-
21
-
-
3242746583
-
Antimicrobial prophylaxis in febrile neutropenia
-
Yoshida M, Ohno R. Antimicrobial prophylaxis in febrile neutropenia. Clin Infect Dis 2004;39 (Suppl 1):S65-7
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Yoshida, M.1
Ohno, R.2
-
22
-
-
3242769763
-
Clinical features of the neutropenic host: definitions and initial evaluation
-
Urabe A. Clinical features of the neutropenic host: definitions and initial evaluation. Clin Infect Dis 2004;39 (Suppl 1):S53-5.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Urabe, A.1
-
23
-
-
3242786240
-
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia
-
Tamura K, Imajo K, Akiyama N, Suzuki K, Urabe A, Ohyashiki K, Tanimoto M, Masaoka T. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia. Clin Infect Dis 2004;39 (Suppl 1):S15-24.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Tamura, K.1
Imajo, K.2
Akiyama, N.3
Suzuki, K.4
Urabe, A.5
Ohyashiki, K.6
Tanimoto, M.7
Masaoka, T.8
-
24
-
-
3242788623
-
Initial empirical antimicrobial therapy: duration and subsequent modifications
-
Tamura K. Initial empirical antimicrobial therapy: duration and subsequent modifications. Clin Infect Dis 2004;39 (Suppl 1):S59-64.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Tamura, K.1
-
25
-
-
3242798759
-
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients
-
Ohyashiki K. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients. Clin Infect Dis 2004;39 (Suppl 1):S56-8
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Ohyashiki, K.1
-
26
-
-
3242759676
-
Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary
-
Masaoka T. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis 2004;39 (Suppl 1):S49-52.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Masaoka, T.1
-
27
-
-
3242748085
-
Microbiological data for patients with febrile neutropenia
-
Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis 2004;39 (Suppl 1): S7-S10.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Kanamaru, A.1
Tatsumi, Y.2
-
28
-
-
0018569077
-
The periodic health, examination., Canadian Task Force on the Periodic Health, Examination
-
Anonymous
-
Anonymous. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979;121:1193-254.
-
(1979)
Can Med Assoc J
, vol.121
, pp. 1193-1254
-
-
-
29
-
-
60549108967
-
Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide survey
-
Choi SM, Park SH, Lee DG, Choi JH, Yoo JH, Shin WS. Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide survey. J Korean Med Sci 2008; 23:941-7.
-
(2008)
J Korean Med Sci
, vol.23
, pp. 941-947
-
-
Choi, S.M.1
Park, S.H.2
Lee, D.G.3
Choi, J.H.4
Yoo, J.H.5
Shin, W.S.6
-
30
-
-
79959817838
-
Comparison of rectal temperature and tympanic membrane
-
Kim HS, Song MG. Comparison of rectal temperature and tympanic membrane. Nurs Sci 1998;10:22-30.
-
(1998)
Nurs Sci
, vol.10
, pp. 22-30
-
-
Kim, H.S.1
Song, M.G.2
-
31
-
-
0031242183
-
Core body temperature measurement: a comparison of axilla, tympanic membrane and pulmonary artery blood temperature
-
Fulbrook P. Core body temperature measurement: a comparison of axilla, tympanic membrane and pulmonary artery blood temperature. Intensive Crit Care Nurs 1997;13:266-72.
-
(1997)
Intensive Crit Care Nurs
, vol.13
, pp. 266-272
-
-
Fulbrook, P.1
-
32
-
-
68949177281
-
A comparison between infrared tympanic thermometry, oral and axilla with rectal thermometry in neutropenic adults
-
Dzarr AA, Kamal M, Baba AA. A comparison between infrared tympanic thermometry, oral and axilla with rectal thermometry in neutropenic adults. Eur J Oncol Nurs 2009; 13:250-4.
-
(2009)
Eur J Oncol Nurs
, vol.13
, pp. 250-254
-
-
Dzarr, A.A.1
Kamal, M.2
Baba, A.A.3
-
33
-
-
46249114667
-
The influence of mucositis on oral thermometry: when fever may not reflect infection
-
Ciuraru NB, Braunstein R, Sulkes A, Stemmer SM. The influence of mucositis on oral thermometry: when fever may not reflect infection. Clin Infect Dis 2008;46:1859-63.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1859-1863
-
-
Ciuraru, N.B.1
Braunstein, R.2
Sulkes, A.3
Stemmer, S.M.4
-
34
-
-
0013877409
-
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
-
Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64: 328-40.
-
(1966)
Ann Intern Med
, vol.64
, pp. 328-340
-
-
Bodey, G.P.1
Buckley, M.2
Sathe, Y.S.3
Freireich, E.J.4
-
35
-
-
0017841794
-
Fever and infection in leukemic patients: a study of 494 consecutive patients
-
Bodey GP, Rodriguez V, Chang HY, Narboni. Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer 1978;41:1610-22.
-
(1978)
Cancer
, vol.41
, pp. 1610-1622
-
-
Bodey, G.P.1
Rodriguez, V.2
Chang, H.Y.3
Narboni4
-
36
-
-
0016805371
-
Clinical presentation of infection in granulocytopenic patients
-
Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975;135:715-9.
-
(1975)
Arch Intern Med
, vol.135
, pp. 715-719
-
-
Sickles, E.A.1
Greene, W.H.2
Wiernik, P.H.3
-
37
-
-
0032977941
-
Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography
-
Heussel CP, Kauczor HU, Heussel GE, Fischer B, Begrich M, Mildenberger P, Thelen M. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999;17:796-805.
-
(1999)
J Clin Oncol
, vol.17
, pp. 796-805
-
-
Heussel, C.P.1
Kauczor, H.U.2
Heussel, G.E.3
Fischer, B.4
Begrich, M.5
Mildenberger, P.6
Thelen, M.7
-
38
-
-
0033904644
-
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
-
Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-51.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3038-3051
-
-
Klastersky, J.1
Paesmans, M.2
Rubenstein, E.B.3
Boyer, M.4
Elting, L.5
Feld, R.6
Gallagher, J.7
Herrstedt, J.8
Rapoport, B.9
Rolston, K.10
Talcott, J.11
-
39
-
-
0024245572
-
The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
-
Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988;148:2561-8.
-
(1988)
Arch Intern Med
, vol.148
, pp. 2561-2568
-
-
Talcott, J.A.1
Finberg, R.2
Mayer, R.J.3
Goldman, L.4
-
40
-
-
0026599442
-
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule
-
Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992; 10:316-22.
-
(1992)
J Clin Oncol
, vol.10
, pp. 316-322
-
-
Talcott, J.A.1
Siegel, R.D.2
Finberg, R.3
Goldman, L.4
-
41
-
-
0027976188
-
Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule
-
Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994;12:107-14.
-
(1994)
J Clin Oncol
, vol.12
, pp. 107-114
-
-
Talcott, J.A.1
Whalen, A.2
Clark, J.3
Rieker, P.P.4
Finberg, R.5
-
42
-
-
79959853542
-
Risk prediction factors in febrile neutropenic patients
-
Jung JS, Kwon KY, Kim KS, Lim YS, Rhee JE, Suh GJ, Youn YK. Risk prediction factors in febrile neutropenic patients. J Korean Soc Emerg Med 2000;11:305-15.
-
(2000)
J Korean Soc Emerg Med
, vol.11
, pp. 305-315
-
-
Jung, J.S.1
Kwon, K.Y.2
Kim, K.S.3
Lim, Y.S.4
Rhee, J.E.5
Suh, G.J.6
Youn, Y.K.7
-
43
-
-
14844336911
-
Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea
-
Yoo JH, Choi SM, Lee DG, Choi JH, Shin WS, Min WS, Kim CC. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea. J Korean Med Sci 2005;20:31-5.
-
(2005)
J Korean Med Sci
, vol.20
, pp. 31-35
-
-
Yoo, J.H.1
Choi, S.M.2
Lee, D.G.3
Choi, J.H.4
Shin, W.S.5
Min, W.S.6
Kim, C.C.7
-
44
-
-
20544469254
-
Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients
-
Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005;142:979-95.
-
(2005)
Ann Intern Med
, vol.142
, pp. 979-995
-
-
Gafter-Gvili, A.1
Fraser, A.2
Paul, M.3
Leibovici, L.4
-
45
-
-
0031934038
-
Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis
-
Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998;16:1179-87.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1179-1187
-
-
Engels, E.A.1
Lau, J.2
Barza, M.3
-
46
-
-
30044438252
-
Antibacterial prophylaxis in patients with cancer and neutropenia
-
author reply 90-4
-
Ito JI, Tegtmeier BR, O'Donnell MR. Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med 2006;354:90-4; author reply 90-4.
-
(2006)
N Engl J Med
, vol.354
, pp. 90-94
-
-
Ito, J.I.1
Tegtmeier, B.R.2
O'Donnell, M.R.3
-
47
-
-
24344445873
-
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
-
Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005;353:988-98.
-
(2005)
N Engl J Med
, vol.353
, pp. 988-998
-
-
Cullen, M.1
Steven, N.2
Billingham, L.3
Gaunt, C.4
Hastings, M.5
Simmonds, P.6
Stuart, N.7
Rea, D.8
Bower, M.9
Fernando, I.10
Huddart, R.11
Gollins, S.12
Stanley, A.13
-
48
-
-
24344471724
-
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
-
Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foa R, Del Favero A. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005;353:977-87.
-
(2005)
N Engl J Med
, vol.353
, pp. 977-987
-
-
Bucaneve, G.1
Micozzi, A.2
Menichetti, F.3
Martino, P.4
Dionisi, M.S.5
Martinelli, G.6
Allione, B.7
D'Antonio, D.8
Buelli, M.9
Nosari, A.M.10
Cilloni, D.11
Zuffa, E.12
Cantaffa, R.13
Specchia, G.14
Amadori, S.15
Fabbiano, F.16
Deliliers, G.L.17
Lauria, F.18
Foa, R.19
Del Favero, A.20
more..
-
49
-
-
0036516673
-
Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial
-
Lee DG, Choi SM, Choi JH, Yoo JH, Park YH, Kim YJ, Lee S, Min CK, Kim HJ, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial. Korean J Intern Med 2002;17:38-44.
-
(2002)
Korean J Intern Med
, vol.17
, pp. 38-44
-
-
Lee, D.G.1
Choi, S.M.2
Choi, J.H.3
Yoo, J.H.4
Park, Y.H.5
Kim, Y.J.6
Lee, S.7
Min, C.K.8
Kim, H.J.9
Kim, D.W.10
Lee, J.W.11
Min, W.S.12
Shin, W.S.13
Kim, C.C.14
-
50
-
-
0034727238
-
Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study
-
Thomas X, Troncy J, Belhabri A, Thiebaut A, Bouheddou N, Michallet M, Fleurette J, Pivot C, Fiere D, Archimbaud E. Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study. Presse Med 2000;29:1745-51.
-
(2000)
Presse Med
, vol.29
, pp. 1745-1751
-
-
Thomas, X.1
Troncy, J.2
Belhabri, A.3
Thiebaut, A.4
Bouheddou, N.5
Michallet, M.6
Fleurette, J.7
Pivot, C.8
Fiere, D.9
Archimbaud, E.10
-
51
-
-
0027415751
-
Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group
-
Talbot GH, Cassileth PA, Paradiso L, Correa-Coronas R, Bond L. Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group. Antimicrob Agents Chemother 1993;37:474-82.
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 474-482
-
-
Talbot, G.H.1
Cassileth, P.A.2
Paradiso, L.3
Correa-Coronas, R.4
Bond, L.5
-
52
-
-
0025881846
-
Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation
-
Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Takvorian T, Mayer R, Kalish L, Finberg R. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation 1991;51:630-6.
-
(1991)
Transplantation
, vol.51
, pp. 630-636
-
-
Lew, M.A.1
Kehoe, K.2
Ritz, J.3
Antman, K.H.4
Nadler, L.5
Takvorian, T.6
Mayer, R.7
Kalish, L.8
Finberg, R.9
-
53
-
-
0023147116
-
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial
-
Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ, Bartlett JG, Saral R, Burke PJ. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1987;106:1-7.
-
(1987)
Ann Intern Med
, vol.106
, pp. 1-7
-
-
Karp, J.E.1
Merz, W.G.2
Hendricksen, C.3
Laughon, B.4
Redden, T.5
Bamberger, B.J.6
Bartlett, J.G.7
Saral, R.8
Burke, P.J.9
-
54
-
-
36849012946
-
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stemcell transplantation: systematic review and meta-analysis
-
Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, Paul M. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stemcell transplantation: systematic review and meta-analysis. J Clin Oncol 2007;25:5471-89.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5471-5489
-
-
Robenshtok, E.1
Gafter-Gvili, A.2
Goldberg, E.3
Weinberger, M.4
Yeshurun, M.5
Leibovici, L.6
Paul, M.7
-
55
-
-
0026597735
-
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
-
Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ, Powderly WG, Silber JL, Horowitz H, Lichtin A, Wolff SN, Mangan KF, Silver SM, Weisdorf D, Ho WG, Gilbert G, Buell D. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
-
(1992)
N Engl J Med
, vol.326
, pp. 845-851
-
-
Goodman, J.L.1
Winston, D.J.2
Greenfield, R.A.3
Chandrasekar, P.H.4
Fox, B.5
Kaizer, H.6
Shadduck, R.K.7
Shea, T.C.8
Stiff, P.9
Friedman, D.J.10
Powderly, W.G.11
Silber, J.L.12
Horowitz, H.13
Lichtin, A.14
Wolff, S.N.15
Mangan, K.F.16
Silver, S.M.17
Weisdorf, D.18
Ho, W.G.19
Gilbert, G.20
Buell, D.21
more..
-
56
-
-
0028997086
-
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study
-
Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis 1995;171:1545-52.
-
(1995)
J Infect Dis
, vol.171
, pp. 1545-1552
-
-
Slavin, M.A.1
Osborne, B.2
Adams, R.3
Levenstein, M.J.4
Schoch, H.G.5
Feldman, A.R.6
Meyers, J.D.7
Bowden, R.A.8
-
57
-
-
0033014809
-
Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group
-
Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis 1999;28:331-40.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 331-340
-
-
Rotstein, C.1
Bow, E.J.2
Laverdiere, M.3
Ioannou, S.4
Carr, D.5
Moghaddam, N.6
-
58
-
-
0027394670
-
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial
-
Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ, Buell DN. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993;118:495-503.
-
(1993)
Ann Intern Med
, vol.118
, pp. 495-503
-
-
Winston, D.J.1
Chandrasekar, P.H.2
Lazarus, H.M.3
Goodman, J.L.4
Silber, J.L.5
Horowitz, H.6
Shadduck, R.K.7
Rosenfeld, C.S.8
Ho, W.G.9
Islam, M.Z.10
Buell, D.N.11
-
59
-
-
0029090675
-
Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias
-
Schaffner A, Schaffner M. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis 1995; 172:1035-41.
-
(1995)
J Infect Dis
, vol.172
, pp. 1035-1041
-
-
Schaffner, A.1
Schaffner, M.2
-
60
-
-
0032812897
-
A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group
-
Young GA, Bosly A, Gibbs DL, Durrant S. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group. Eur J Cancer 1999;35:1208-13.
-
(1999)
Eur J Cancer
, vol.35
, pp. 1208-1213
-
-
Young, G.A.1
Bosly, A.2
Gibbs, D.L.3
Durrant, S.4
-
61
-
-
0027248742
-
Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group
-
Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. J Antimicrob Chemother 1993;31:973-84.
-
(1993)
J Antimicrob Chemother
, vol.31
, pp. 973-984
-
-
Philpott-Howard, J.N.1
Wade, J.J.2
Mufti, G.J.3
Brammer, K.W.4
Ehninger, G.5
-
62
-
-
0028243197
-
Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B
-
Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, Ricci P, Carotenuto M, Liso V, Nosari AM, Barbui T, Fasola G, Mandelli F. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med 1994;120: 913-8.
-
(1994)
Ann Intern Med
, vol.120
, pp. 913-918
-
-
Menichetti, F.1
Del Favero, A.2
Martino, P.3
Bucaneve, G.4
Micozzi, A.5
D'Antonio, D.6
Ricci, P.7
Carotenuto, M.8
Liso, V.9
Nosari, A.M.10
Barbui, T.11
Fasola, G.12
Mandelli, F.13
-
63
-
-
0029398847
-
Efficacy of different prophylactic antifungal regimens in bone marrow transplantation
-
Annaloro C, Oriana A, Tagliaferri E, Bertolli V, Della Volpe A, Soligo D, Ibatici A, Pozzoli E, Lambertenghi Deliliers GL. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation. Haematologica 1995;80:512-7.
-
(1995)
Haematologica
, vol.80
, pp. 512-517
-
-
Annaloro, C.1
Oriana, A.2
Tagliaferri, E.3
Bertolli, V.4
Della Volpe, A.5
Soligo, D.6
Ibatici, A.7
Pozzoli, E.8
Lambertenghi Deliliers, G.L.9
-
64
-
-
0032899153
-
Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology
-
Huijgens PC, Simoons-Smit AM, van Loenen AC, Prooy E, van Tinteren H, Ossenkoppele GJ, Jonkhoff AR. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. J Clin Pathol 1999;52:376-80.
-
(1999)
J Clin Pathol
, vol.52
, pp. 376-380
-
-
Huijgens, P.C.1
Simoons-Smit, A.M.2
van Loenen, A.C.3
Prooy, E.4
van Tinteren, H.5
Ossenkoppele, G.J.6
Jonkhoff, A.R.7
-
65
-
-
31544444209
-
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
-
Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hanel M, Dolken G, Junghanss C, Andreesen R, Bertz H. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. J Antimicrob Chemother 2006;57: 317-25.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 317-325
-
-
Glasmacher, A.1
Cornely, O.2
Ullmann, A.J.3
Wedding, U.4
Bodenstein, H.5
Wandt, H.6
Boewer, C.7
Pasold, R.8
Wolf, H.H.9
Hanel, M.10
Dolken, G.11
Junghanss, C.12
Andreesen, R.13
Bertz, H.14
-
66
-
-
0842328814
-
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
-
Marr KA, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee SA, Nichols WG, Musher B, Corey L. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004;103:1527-33.
-
(2004)
Blood
, vol.103
, pp. 1527-1533
-
-
Marr, K.A.1
Crippa, F.2
Leisenring, W.3
Hoyle, M.4
Boeckh, M.5
Balajee, S.A.6
Nichols, W.G.7
Musher, B.8
Corey, L.9
-
67
-
-
0032991690
-
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U. K. Multicentre Antifungal Prophylaxis Study Group
-
Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol 1999;105:901-11.
-
(1999)
Br J Haematol
, vol.105
, pp. 901-911
-
-
Morgenstern, G.R.1
Prentice, A.G.2
Prentice, H.G.3
Ropner, J.E.4
Schey, S.A.5
Warnock, D.W.6
-
68
-
-
33745755772
-
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients
-
Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2006;38:127-34.
-
(2006)
Bone Marrow Transplant
, vol.38
, pp. 127-134
-
-
Oren, I.1
Rowe, J.M.2
Sprecher, H.3
Tamir, A.4
Benyamini, N.5
Akria, L.6
Gorelik, A.7
Dally, N.8
Zuckerman, T.9
Haddad, N.10
Fineman, R.11
Dann, E.J.12
-
69
-
-
0037736664
-
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial
-
Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 2003;138:705-13.
-
(2003)
Ann Intern Med
, vol.138
, pp. 705-713
-
-
Winston, D.J.1
Maziarz, R.T.2
Chandrasekar, P.H.3
Lazarus, H.M.4
Goldman, M.5
Blumer, J.L.6
Leitz, G.J.7
Territo, M.C.8
-
70
-
-
33746840071
-
Heart failure induced by non-cardiac drugs
-
Slordal L, Spigset O. Heart failure induced by non-cardiac drugs. Drug Saf 2006;29:567-86.
-
(2006)
Drug Saf
, vol.29
, pp. 567-586
-
-
Slordal, L.1
Spigset, O.2
-
71
-
-
40449105146
-
Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent
-
Nagappan V, Deresinski S. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clin Infect Dis 2007;45:1610-7.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 1610-1617
-
-
Nagappan, V.1
Deresinski, S.2
-
72
-
-
84863539110
-
-
Schering-Plough. Schering-Plough announces FDA approval of NOXAFIL(R) (posaconazole) for treatment of oropharyngeal candidiasis (OPC). Available at. Accessed 15 May 2011
-
Schering-Plough. Schering-Plough announces FDA approval of NOXAFIL(R) (posaconazole) for treatment of oropharyngeal candidiasis (OPC). Available at: http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-23-2006/0004456852&EDATE=. Accessed 15 May 2011.
-
-
-
-
73
-
-
33846462456
-
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
-
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356:348-59.
-
(2007)
N Engl J Med
, vol.356
, pp. 348-359
-
-
Cornely, O.A.1
Maertens, J.2
Winston, D.J.3
Perfect, J.4
Ullmann, A.J.5
Walsh, T.J.6
Helfgott, D.7
Holowiecki, J.8
Stockelberg, D.9
Goh, Y.T.10
Petrini, M.11
Hardalo, C.12
Suresh, R.13
Angulo-Gonzalez, D.14
-
74
-
-
8744314133
-
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
-
van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004;39:1407-16.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 1407-1416
-
-
van Burik, J.A.1
Ratanatharathorn, V.2
Stepan, D.E.3
Miller, C.B.4
Lipton, J.H.5
Vesole, D.H.6
Bunin, N.7
Wall, D.A.8
Hiemenz, J.W.9
Satoi, Y.10
Lee, J.M.11
Walsh, T.J.12
-
75
-
-
64249152006
-
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell trans plantation
-
Hiramatsu Y, Maeda Y, Fujii N, Saito T, Nawa Y, Hara M, Yano T, Asakura S, Sunami K, Tabayashi T, Miyata A, Matsuoka K, Shinagawa K, Ikeda K, Matsuo K, Tanimoto M. Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell trans plantation. Int J Hematol 2008;88:588-95.
-
(2008)
Int J Hematol
, vol.88
, pp. 588-595
-
-
Hiramatsu, Y.1
Maeda, Y.2
Fujii, N.3
Saito, T.4
Nawa, Y.5
Hara, M.6
Yano, T.7
Asakura, S.8
Sunami, K.9
Tabayashi, T.10
Miyata, A.11
Matsuoka, K.12
Shinagawa, K.13
Ikeda, K.14
Matsuo, K.15
Tanimoto, M.16
-
76
-
-
0034036969
-
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
-
Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant 2000;25:853-9.
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 853-859
-
-
Wolff, S.N.1
Fay, J.2
Stevens, D.3
Herzig, R.H.4
Pohlman, B.5
Bolwell, B.6
Lynch, J.7
Ericson, S.8
Freytes, C.O.9
LeMaistre, F.10
Collins, R.11
Pineiro, L.12
Greer, J.13
Stein, R.14
Goodman, S.A.15
Dummer, S.16
-
77
-
-
0028220652
-
Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B
-
Bodey GP, Anaissie EJ, Elting LS, Estey E, O'Brien S, Kantarjian H. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B. Cancer 1994;73:2099-106.
-
(1994)
Cancer
, vol.73
, pp. 2099-2106
-
-
Bodey, G.P.1
Anaissie, E.J.2
Elting, L.S.3
Estey, E.4
O'Brien, S.5
Kantarjian, H.6
-
78
-
-
0027715740
-
Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients
-
Tollemar J, Ringden O, Andersson S, Sundberg B, Ljungman P, Tyden G. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1993;12:577-82.
-
(1993)
Bone Marrow Transplant
, vol.12
, pp. 577-582
-
-
Tollemar, J.1
Ringden, O.2
Andersson, S.3
Sundberg, B.4
Ljungman, P.5
Tyden, G.6
-
79
-
-
0032913885
-
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebocontrolled study
-
Kelsey SM, Goldman JM, McCann S, Newland AC, Scarffe JH, Oppenheim BA, Mufti GJ. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebocontrolled study. Bone Marrow Transplant 1999;23:163-8.
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 163-168
-
-
Kelsey, S.M.1
Goldman, J.M.2
McCann, S.3
Newland, A.C.4
Scarffe, J.H.5
Oppenheim, B.A.6
Mufti, G.J.7
-
80
-
-
0028334182
-
Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies
-
Tollemar J, Hockerstedt K, Ericzon BG, Sundberg B, Ringden O. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies. Transplant Proc 1994;26:1833.
-
(1994)
Transplant Proc
, vol.26
, pp. 1833
-
-
Tollemar, J.1
Hockerstedt, K.2
Ericzon, B.G.3
Sundberg, B.4
Ringden, O.5
-
81
-
-
33747892111
-
Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
-
Penack O, Schwartz S, Martus P, Reinwald M, Schmidt-Hieber M, Thiel E, Blau IW. Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial. Ann Oncol 2006;17:1306-12.
-
(2006)
Ann Oncol
, vol.17
, pp. 1306-1312
-
-
Penack, O.1
Schwartz, S.2
Martus, P.3
Reinwald, M.4
Schmidt-Hieber, M.5
Thiel, E.6
Blau, I.W.7
-
82
-
-
0033152309
-
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial
-
Schwartz S, Behre G, Heinemann V, Wandt H, Schilling E, Arning M, Trittin A, Kern WV, Boenisch O, Bosse D, Lenz K, Ludwig WD, Hiddemann W, Siegert W, Beyer J. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood 1999;93: 3654-61.
-
(1999)
Blood
, vol.93
, pp. 3654-3661
-
-
Schwartz, S.1
Behre, G.2
Heinemann, V.3
Wandt, H.4
Schilling, E.5
Arning, M.6
Trittin, A.7
Kern, W.V.8
Boenisch, O.9
Bosse, D.10
Lenz, K.11
Ludwig, W.D.12
Hiddemann, W.13
Siegert, W.14
Beyer, J.15
-
83
-
-
33645708611
-
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation
-
Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2006;8:13-20.
-
(2006)
Transpl Infect Dis
, vol.8
, pp. 13-20
-
-
Alexander, B.D.1
Dodds Ashley, E.S.2
Addison, R.M.3
Alspaugh, J.A.4
Chao, N.J.5
Perfect, J.R.6
-
84
-
-
42549085783
-
Lugtenburg PJ, de Marie S. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial
-
Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, Lowenberg B, Vulto A, Lugtenburg PJ, de Marie S. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis 2008;46:1401-8.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1401-1408
-
-
Rijnders, B.J.1
Cornelissen, J.J.2
Slobbe, L.3
Becker, M.J.4
Doorduijn, J.K.5
Hop, W.C.6
Ruijgrok, E.J.7
Lowenberg, B.8
Vulto, A.9
-
85
-
-
79951772903
-
Itraconazole oral solution versus fluconazole syrup for prevention of invasive fungal infections in patients receiving hematopoietic stem cell transplantation: prospective, randomized, comparative clinical trial
-
Choi SM, Lee DG, Choi JH, Park SH, Eom KS, Kim YJ, Kim HJ, Min CK, Yoo JH, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Itraconazole oral solution versus fluconazole syrup for prevention of invasive fungal infections in patients receiving hematopoietic stem cell transplantation: prospective, randomized, comparative clinical trial. Infect Chemother 2005;37: 71-8.
-
(2005)
Infect Chemother
, vol.37
, pp. 71-78
-
-
Choi, S.M.1
Lee, D.G.2
Choi, J.H.3
Park, S.H.4
Eom, K.S.5
Kim, Y.J.6
Kim, H.J.7
Min, C.K.8
Yoo, J.H.9
Kim, D.W.10
Lee, J.W.11
Min, W.S.12
Shin, W.S.13
Kim, C.C.14
-
86
-
-
0033047475
-
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto
-
Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagano L, Leoni P, Specchia G, Caiozzo A, Raimondi R, Mandelli F. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Clin Infect Dis 1999;28:250-5.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 250-255
-
-
Menichetti, F.1
Del Favero, A.2
Martino, P.3
Bucaneve, G.4
Micozzi, A.5
Girmenia, C.6
Barbabietola, G.7
Pagano, L.8
Leoni, P.9
Specchia, G.10
Caiozzo, A.11
Raimondi, R.12
Mandelli, F.13
-
87
-
-
0034099841
-
A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients
-
Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Clin Infect Dis 2000;30:300-5.
-
(2000)
Clin Infect Dis
, vol.30
, pp. 300-305
-
-
Nucci, M.1
Biasoli, I.2
Akiti, T.3
Silveira, F.4
Solza, C.5
Barreiros, G.6
Spector, N.7
Derossi, A.8
Pulcheri, W.9
-
88
-
-
0027819334
-
Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies
-
Akiyama H, Mori S, Tanikawa S, Sakamaki H, Onozawa Y. Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies. Mycoses 1993;36:373-8.
-
(1993)
Mycoses
, vol.36
, pp. 373-378
-
-
Akiyama, H.1
Mori, S.2
Tanikawa, S.3
Sakamaki, H.4
Onozawa, Y.5
-
89
-
-
0028039104
-
The prophylactic use of low-dose amphotericin B in bone marrow transplant patients
-
Riley DK, Pavia AT, Beatty PG, Petersen FB, Spruance JL, Stokes R, Evans TG. The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med 1994;97:509-14.
-
(1994)
Am J Med
, vol.97
, pp. 509-514
-
-
Riley, D.K.1
Pavia, A.T.2
Beatty, P.G.3
Petersen, F.B.4
Spruance, J.L.5
Stokes, R.6
Evans, T.G.7
-
90
-
-
0037367618
-
Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia
-
Kaptan K, Ural AU, Cetin T, Avcu F, Beyan C, Yalcin A. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia. J Infect Chemother 2003;9:40-5.
-
(2003)
J Infect Chemother
, vol.9
, pp. 40-45
-
-
Kaptan, K.1
Ural, A.U.2
Cetin, T.3
Avcu, F.4
Beyan, C.5
Yalcin, A.6
-
91
-
-
0032527958
-
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group
-
Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wormann B, Buchner T, Hiddemann W. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. Cancer 1998;83:291-301.
-
(1998)
Cancer
, vol.83
, pp. 291-301
-
-
Kern, W.1
Behre, G.2
Rudolf, T.3
Kerkhoff, A.4
Grote-Metke, A.5
Eimermacher, H.6
Kubica, U.7
Wormann, B.8
Buchner, T.9
Hiddemann, W.10
-
92
-
-
0141617351
-
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution
-
Lass-Florl C, Gunsilius E, Gastl G, Englisch M, Koch G, Ulmer H, Dierich MP, Petzer A. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol 2003;82: 565-9.
-
(2003)
Ann Hematol
, vol.82
, pp. 565-569
-
-
Lass-Florl, C.1
Gunsilius, E.2
Gastl, G.3
Englisch, M.4
Koch, G.5
Ulmer, H.6
Dierich, M.P.7
Petzer, A.8
-
93
-
-
85005137223
-
Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary?
-
Van Delden C, Lew DP, Chapuis B, Rohner P, Hirschel B. Antifungal Prophylaxis in Severely Neutropenic Patients: How Much Fluconazole is Necessary? Clin Microbiol Infect 1995;1:24-30.
-
(1995)
Clin Microbiol Infect
, vol.1
, pp. 24-30
-
-
Van Delden, C.1
Lew, D.P.2
Chapuis, B.3
Rohner, P.4
Hirschel, B.5
-
94
-
-
33846410666
-
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
-
Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007;356:335-47.
-
(2007)
N Engl J Med
, vol.356
, pp. 335-347
-
-
Ullmann, A.J.1
Lipton, J.H.2
Vesole, D.H.3
Chandrasekar, P.4
Langston, A.5
Tarantolo, S.R.6
Greinix, H.7
Morais de Azevedo, W.8
Reddy, V.9
Boparai, N.10
Pedicone, L.11
Patino, H.12
Durrant, S.13
-
95
-
-
0023258601
-
Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis
-
Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987;316:1627-32.
-
(1987)
N Engl J Med
, vol.316
, pp. 1627-1632
-
-
Hughes, W.T.1
Rivera, G.K.2
Schell, M.J.3
Thornton, D.4
Lott, L.5
-
96
-
-
34548435533
-
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIVinfected patients: systematic review and meta-analysis of randomized controlled trials
-
Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIVinfected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 2007;82:1052-9.
-
(2007)
Mayo Clin Proc
, vol.82
, pp. 1052-1059
-
-
Green, H.1
Paul, M.2
Vidal, L.3
Leibovici, L.4
-
97
-
-
44949149229
-
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
-
CD005590
-
Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007: CD005590.
-
(2007)
Cochrane Database Syst Rev
-
-
Green, H.1
Paul, M.2
Vidal, L.3
Leibovici, L.4
-
98
-
-
33645982603
-
Infectious complications of chronic lymphocytic leukemia
-
Wadhwa PD, Morrison VA. Infectious complications of chronic lymphocytic leukemia. Semin Oncol 2006;33:240-9.
-
(2006)
Semin Oncol
, vol.33
, pp. 240-249
-
-
Wadhwa, P.D.1
Morrison, V.A.2
-
99
-
-
33745299246
-
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
-
Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis 2006;43:16-24.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 16-24
-
-
Martin, S.I.1
Marty, F.M.2
Fiumara, K.3
Treon, S.P.4
Gribben, J.G.5
Baden, L.R.6
-
100
-
-
0030927872
-
Prophylactic strategies to meet infectious complications in fludarabine-treated CLL
-
Sudhoff T, Arning M, Schneider W. Prophylactic strategies to meet infectious complications in fludarabine-treated CLL. Leukemia 1997;11 (Suppl 2):S38-41.
-
(1997)
Leukemia
, vol.11
, Issue.SUPPL. 2
-
-
Sudhoff, T.1
Arning, M.2
Schneider, W.3
-
101
-
-
0033503231
-
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
-
El-Sadr WM, Luskin-Hawk R, Yurik TM, Walker J, Abrams D, John SL, Sherer R, Crane L, Labriola A, Caras S, Pulling C, Hafner R. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Clin Infect Dis 1999; 29:775-83.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 775-783
-
-
El-Sadr, W.M.1
Luskin-Hawk, R.2
Yurik, T.M.3
Walker, J.4
Abrams, D.5
John, S.L.6
Sherer, R.7
Crane, L.8
Labriola, A.9
Caras, S.10
Pulling, C.11
Hafner, R.12
-
102
-
-
0033631194
-
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections
-
Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 2000; 6:35-43.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 35-43
-
-
Vasconcelles, M.J.1
Bernardo, M.V.2
King, C.3
Weller, E.A.4
Antin, J.H.5
-
103
-
-
0033401315
-
High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis
-
Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis 1999;29:1467-71.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 1467-1471
-
-
Souza, J.P.1
Boeckh, M.2
Gooley, T.A.3
Flowers, M.E.4
Crawford, S.W.5
-
104
-
-
0018935309
-
Infection with herpes simplex virus and cell-mediated immunity after marrow transplant
-
Meyers JD, Flournoy N, Thomas ED. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis 1980;142:338-46.
-
(1980)
J Infect Dis
, vol.142
, pp. 338-346
-
-
Meyers, J.D.1
Flournoy, N.2
Thomas, E.D.3
-
105
-
-
0025076681
-
Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection
-
Schubert MM, Peterson DE, Flournoy N, Meyers JD, Truelove EL. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol 1990;70:286-93.
-
(1990)
Oral Surg Oral Med Oral Pathol
, vol.70
, pp. 286-293
-
-
Schubert, M.M.1
Peterson, D.E.2
Flournoy, N.3
Meyers, J.D.4
Truelove, E.L.5
-
106
-
-
0035115843
-
Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer
-
Barton T, Collis T, Stadtmauer E, Schuster M. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin Infect Dis 2001;32:391-5.
-
(2001)
Clin Infect Dis
, vol.32
, pp. 391-395
-
-
Barton, T.1
Collis, T.2
Stadtmauer, E.3
Schuster, M.4
-
107
-
-
0033376138
-
Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma
-
Herrmann RP, Trent M, Cooney J, Cannell PK. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 1999;24:1213-7.
-
(1999)
Bone Marrow Transplant
, vol.24
, pp. 1213-1217
-
-
Herrmann, R.P.1
Trent, M.2
Cooney, J.3
Cannell, P.K.4
-
108
-
-
0032981810
-
Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option
-
Seropian S, Nadkarni R, Jillella AP, Salloum E, Burtness B, Hu GL, Zelterman D, Cooper DL. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone Marrow Transplant 1999;23: 599-605.
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 599-605
-
-
Seropian, S.1
Nadkarni, R.2
Jillella, A.P.3
Salloum, E.4
Burtness, B.5
Hu, G.L.6
Zelterman, D.7
Cooper, D.L.8
-
109
-
-
79959816547
-
Prevalence of antibody to herpes simplex virus
-
Lee JT, Kim YT. Prevalence of antibody to herpes simplex virus. Korean J Dermatol 1993;31:38-46.
-
(1993)
Korean J Dermatol
, vol.31
, pp. 38-46
-
-
Lee, J.T.1
Kim, Y.T.2
-
111
-
-
70450248564
-
Antiviral prophylaxis in haematological patients: systematic review and meta-analysis
-
Yahav D, Gafter-Gvili A, Muchtar E, Skalsky K, Kariv G, Yeshurun M, Leibovici L, Paul M. Antiviral prophylaxis in haematological patients: systematic review and meta-analysis. Eur J Cancer 2009;45:3131-48.
-
(2009)
Eur J Cancer
, vol.45
, pp. 3131-3148
-
-
Yahav, D.1
Gafter-Gvili, A.2
Muchtar, E.3
Skalsky, K.4
Kariv, G.5
Yeshurun, M.6
Leibovici, L.7
Paul, M.8
-
112
-
-
0036957592
-
Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients
-
Liesveld JL, Abboud CN, Ifthikharuddin JJ, Lancet JE, Wedow LA, Oliva J, Stamm CG, Nichols D. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients. Biol Blood Marrow Transplant 2002;8:662-5.
-
(2002)
Biol Blood Marrow Transplant
, vol.8
, pp. 662-665
-
-
Liesveld, J.L.1
Abboud, C.N.2
Ifthikharuddin, J.J.3
Lancet, J.E.4
Wedow, L.A.5
Oliva, J.6
Stamm, C.G.7
Nichols, D.8
-
113
-
-
0036785182
-
Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients
-
Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox VC, Ransier A, Barnett MJ, Marra F. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients. Ann Pharmacother 2002;36:1525-31.
-
(2002)
Ann Pharmacother
, vol.36
, pp. 1525-1531
-
-
Warkentin, D.I.1
Epstein, J.B.2
Campbell, L.M.3
Yip, J.G.4
Cox, V.C.5
Ransier, A.6
Barnett, M.J.7
Marra, F.8
-
114
-
-
0021267945
-
Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation
-
Wade JC, Newton B, Flournoy N, Meyers JD. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 1984;100:823-8.
-
(1984)
Ann Intern Med
, vol.100
, pp. 823-828
-
-
Wade, J.C.1
Newton, B.2
Flournoy, N.3
Meyers, J.D.4
-
115
-
-
70350774376
-
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
-
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant 2009;44:453-5.
-
(2009)
Preface. Bone Marrow Transplant
, vol.44
, pp. 453-455
-
-
Tomblyn, M.1
Chiller, T.2
Einsele, H.3
Gress, R.4
Sepkowitz, K.5
Storek, J.6
Wingard, J.R.7
Young, J.A.8
Boeckh, M.J.9
-
116
-
-
27744515408
-
Infections in patients with acute leukemia: comparison of induction chemotherapy croup and reinduction chemotherapy group
-
Choi SM, Lee DG, Park YH, Kim YJ, Kim HJ, Lee S, Choi JH, Yoo JH, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Infections in patients with acute leukemia: comparison of induction chemotherapy croup and reinduction chemotherapy group. Infect Chemother 2003;35:78-85.
-
(2003)
Infect Chemother
, vol.35
, pp. 78-85
-
-
Choi, S.M.1
Lee, D.G.2
Park, Y.H.3
Kim, Y.J.4
Kim, H.J.5
Lee, S.6
Choi, J.H.7
Yoo, J.H.8
Kim, D.W.9
Lee, J.W.10
Min, W.S.11
Shin, W.S.12
Kim, C.C.13
-
117
-
-
39049133915
-
Infections in patients with acute leukemia (1993-1996)
-
Kim HB, Park SW, Kim US, Kim JW, Shin DH, Oh M, Park S, Kim BK, Choe KW. Infections in patients with acute leukemia (1993-1996). Korean J Hematol 1999;34:359-65.
-
(1999)
Korean J Hematol
, vol.34
, pp. 359-365
-
-
Kim, H.B.1
Park, S.W.2
Kim, U.S.3
Kim, J.W.4
Shin, D.H.5
Oh, M.6
Park, S.7
Kim, B.K.8
Choe, K.W.9
-
118
-
-
33646806133
-
Current trends of infectious complications following hematopoietic stem cell transplantation in a single center
-
Park SH, Choi SM, Lee DG, Choi JH, Yoo JH, Lee JW, Min WS, Shin WS, Kim CC. Current trends of infectious complications following hematopoietic stem cell transplantation in a single center. J Korean Med Sci 2006;21:199-207.
-
(2006)
J Korean Med Sci
, vol.21
, pp. 199-207
-
-
Park, S.H.1
Choi, S.M.2
Lee, D.G.3
Choi, J.H.4
Yoo, J.H.5
Lee, J.W.6
Min, W.S.7
Shin, W.S.8
Kim, C.C.9
-
119
-
-
39049098593
-
Clinical aspects and prognostic factors of neutropenic fever in leukemic patients: 1996-2001
-
Rho YH, Lee YJ, Lee J, Eom JS, Sohn JW, Choi CW, Cheoung HJ, Kim WJ, Kim MJ, Kim JS, Park SC. Clinical aspects and prognostic factors of neutropenic fever in leukemic patients: 1996-2001. Korean J Infect Dis 2002;34:152-9.
-
(2002)
Korean J Infect Dis
, vol.34
, pp. 152-159
-
-
Rho, Y.H.1
Lee, Y.J.2
Lee, J.3
Eom, J.S.4
Sohn, J.W.5
Choi, C.W.6
Cheoung, H.J.7
Kim, W.J.8
Kim, M.J.9
Kim, J.S.10
Park, S.C.11
-
120
-
-
79959839866
-
Profiles of infectious complications on the outcomes for the recipients of allogeneic hematopoietic stem cell transplantation
-
Rhee JY, Jang EH, Kim ST, Wi YM, Son KM, Cheong HS, Ki HK, Oh WS, Ki Hyun Kim MD, Jung CW, Kim WS, Park K, Peck KR, Song JH. Profiles of infectious complications on the outcomes for the recipients of allogeneic hematopoietic stem cell transplantation. Korean J Med 2007;72:200-8.
-
(2007)
Korean J Med
, vol.72
, pp. 200-208
-
-
Rhee, J.Y.1
Jang, E.H.2
Kim, S.T.3
Wi, Y.M.4
Son, K.M.5
Cheong, H.S.6
Ki, H.K.7
Oh, W.S.8
Ki Hyun Kim, M.D.9
Jung, C.W.10
Kim, W.S.11
Park, K.12
Peck, K.R.13
Song, J.H.14
-
121
-
-
79959823935
-
The patterns of infection and therapy in cancer patients receiving chemotherapy
-
Kim JS, Oh JM. The patterns of infection and therapy in cancer patients receiving chemotherapy. J Kor Soc Health-Syst Pharm 2000;17:481-500.
-
(2000)
J Kor Soc Health-Syst Pharm
, vol.17
, pp. 481-500
-
-
Kim, J.S.1
Oh, J.M.2
-
122
-
-
0033615008
-
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
-
Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999;341:305-11.
-
(1999)
N Engl J Med
, vol.341
, pp. 305-311
-
-
Freifeld, A.1
Marchigiani, D.2
Walsh, T.3
Chanock, S.4
Lewis, L.5
Hiemenz, J.6
Hiemenz, S.7
Hicks, J.E.8
Gill, V.9
Steinberg, S.M.10
Pizzo, P.A.11
-
123
-
-
0032893747
-
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial
-
Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gomez C, Ruiz A, Garcia-Carbonero R, Cortes-Funes H. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. Cancer 1999;85:213-9.
-
(1999)
Cancer
, vol.85
, pp. 213-219
-
-
Hidalgo, M.1
Hornedo, J.2
Lumbreras, C.3
Trigo, J.M.4
Colomer, R.5
Perea, S.6
Gomez, C.7
Ruiz, A.8
Garcia-Carbonero, R.9
Cortes-Funes, H.10
-
124
-
-
0033614926
-
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer
-
Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1999; 341:312-8.
-
(1999)
N Engl J Med
, vol.341
, pp. 312-318
-
-
Kern, W.V.1
Cometta, A.2
De Bock, R.3
Langenaeken, J.4
Paesmans, M.5
Gaya, H.6
-
125
-
-
0028934175
-
Feasibility of outpatient management of fever in cancer patients with lowrisk neutropenia: results of a prospective randomized trial
-
Malik IA, Khan WA, Karim M, Aziz Z, Khan MA. Feasibility of outpatient management of fever in cancer patients with lowrisk neutropenia: results of a prospective randomized trial. Am J Med 1995;98:224-31.
-
(1995)
Am J Med
, vol.98
, pp. 224-231
-
-
Malik, I.A.1
Khan, W.A.2
Karim, M.3
Aziz, Z.4
Khan, M.A.5
-
126
-
-
0029884724
-
Early empiric antibiotic therapy for febrile neutropenia patients at low risk
-
Rolston KV, Rubenstein EB, Freifeld A. Early empiric antibiotic therapy for febrile neutropenia patients at low risk. Infect Dis Clin North Am 1996;10:223-37.
-
(1996)
Infect Dis Clin North Am
, vol.10
, pp. 223-237
-
-
Rolston, K.V.1
Rubenstein, E.B.2
Freifeld, A.3
-
127
-
-
84863556243
-
Oral moxifloxacin for outpatient treatment of lowrisk, febrile neutropenic patients
-
Rolston KV, Frisbee-Hume SE, Patel S, Manzullo EF, Benjamin RS. Oral moxifloxacin for outpatient treatment of lowrisk, febrile neutropenic patients. Support Care Cancer 2009.
-
(2009)
Support Care Cancer
-
-
Rolston, K.V.1
Frisbee-Hume, S.E.2
Patel, S.3
Manzullo, E.F.4
Benjamin, R.S.5
-
128
-
-
0034176384
-
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer
-
Aquino VM, Herrera L, Sandler ES, Buchanan GR. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 2000; 88:1710-4.
-
(2000)
Cancer
, vol.88
, pp. 1710-1714
-
-
Aquino, V.M.1
Herrera, L.2
Sandler, E.S.3
Buchanan, G.R.4
-
129
-
-
0034426121
-
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever
-
Giamarellou H, Bassaris HP, Petrikkos G, Busch W, Voulgarelis M, Antoniadou A, Grouzi E, Zoumbos N. Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever. Antimicrob Agents Chemother 2000;44:3264-71.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 3264-3271
-
-
Giamarellou, H.1
Bassaris, H.P.2
Petrikkos, G.3
Busch, W.4
Voulgarelis, M.5
Antoniadou, A.6
Grouzi, E.7
Zoumbos, N.8
-
130
-
-
0032998935
-
Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy
-
Kerr KG, Armitage HT, McWhinney PH. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy. Support Care Cancer 1999;7:28-30.
-
(1999)
Support Care Cancer
, vol.7
, pp. 28-30
-
-
Kerr, K.G.1
Armitage, H.T.2
McWhinney, P.H.3
-
131
-
-
0028346573
-
Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group
-
De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group. Ann Intern Med 1994;120:834-44.
-
(1994)
Ann Intern Med
, vol.120
, pp. 834-844
-
-
De Pauw, B.E.1
Deresinski, S.C.2
Feld, R.3
Lane-Allman, E.F.4
Donnelly, J.P.5
-
132
-
-
9244228971
-
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
-
Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, Bucaneve G, Crokaert F, Kern WV, Klastersky J, Langenaeken I, Micozzi A, Padmos A, Paesmans M, Viscoli C, Glauser MP. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother 1996;40:1108-15.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 1108-1115
-
-
Cometta, A.1
Calandra, T.2
Gaya, H.3
Zinner, S.H.4
de Bock, R.5
Del Favero, A.6
Bucaneve, G.7
Crokaert, F.8
Kern, W.V.9
Klastersky, J.10
Langenaeken, I.11
Micozzi, A.12
Padmos, A.13
Paesmans, M.14
Viscoli, C.15
Glauser, M.P.16
-
133
-
-
0029002765
-
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group
-
Rubinstein E, Lode H, Grassi C. Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group. Clin Infect Dis 1995;20:1217-28.
-
(1995)
Clin Infect Dis
, vol.20
, pp. 1217-1228
-
-
Rubinstein, E.1
Lode, H.2
Grassi, C.3
-
134
-
-
0025987202
-
Betalactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone
-
Winston DJ, Ho WG, Bruckner DA, Champlin RE. Betalactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Ann Intern Med 1991;115:849-59.
-
(1991)
Ann Intern Med
, vol.115
, pp. 849-859
-
-
Winston, D.J.1
Ho, W.G.2
Bruckner, D.A.3
Champlin, R.E.4
-
135
-
-
0022547096
-
A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
-
Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986;315:552-8.
-
(1986)
N Engl J Med
, vol.315
, pp. 552-558
-
-
Pizzo, P.A.1
Hathorn, J.W.2
Hiemenz, J.3
Browne, M.4
Commers, J.5
Cotton, D.6
Gress, J.7
Longo, D.8
Marshall, D.9
McKnight, J.10
-
136
-
-
0031934238
-
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients
-
Behre G, Link H, Maschmeyer G, Meyer P, Paaz U, Wilhelm M, Hiddemann W. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients. Ann Hematol 1998;76:73-80.
-
(1998)
Ann Hematol
, vol.76
, pp. 73-80
-
-
Behre, G.1
Link, H.2
Maschmeyer, G.3
Meyer, P.4
Paaz, U.5
Wilhelm, M.6
Hiddemann, W.7
-
137
-
-
0032551404
-
Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study
-
Bohme A, Shah PM, Stille W, Hoelzer D. Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study. Eur J Med Res 1998;3:324-30.
-
(1998)
Eur J Med Res
, vol.3
, pp. 324-330
-
-
Bohme, A.1
Shah, P.M.2
Stille, W.3
Hoelzer, D.4
-
138
-
-
0035887790
-
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia
-
Del Favero A, Menichetti F, Martino P, Bucaneve G, Micozzi A, Gentile G, Furno P, Russo D, D'Antonio D, Ricci P, Martino B, Mandelli F. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis 2001;33:1295-301.
-
(2001)
Clin Infect Dis
, vol.33
, pp. 1295-1301
-
-
Del Favero, A.1
Menichetti, F.2
Martino, P.3
Bucaneve, G.4
Micozzi, A.5
Gentile, G.6
Furno, P.7
Russo, D.8
D'Antonio, D.9
Ricci, P.10
Martino, B.11
Mandelli, F.12
-
139
-
-
0032875409
-
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in pa tients without previous prophylactic antibiotics. Meropenem Study Group of Turkey
-
Akova M, Akan H, Korten V, Biberoglu K, Hayran M, Unal S, Kars A, Kansu E. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in pa tients without previous prophylactic antibiotics. Meropenem Study Group of Turkey. Int J Antimicrob Agents 1999;13:15-9.
-
(1999)
Int J Antimicrob Agents
, vol.13
, pp. 15-19
-
-
Akova, M.1
Akan, H.2
Korten, V.3
Biberoglu, K.4
Hayran, M.5
Unal, S.6
Kars, A.7
Kansu, E.8
-
140
-
-
0030802949
-
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients
-
Yamamura D, Gucalp R, Carlisle P, Cimino M, Roberts J, Rotstein C. Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients. Antimicrob Agents Chemother 1997;41: 1704-8.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 1704-1708
-
-
Yamamura, D.1
Gucalp, R.2
Carlisle, P.3
Cimino, M.4
Roberts, J.5
Rotstein, C.6
-
141
-
-
0028834128
-
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem
-
Freifeld AG, Walsh T, Marshall D, Gress J, Steinberg SM, Hathorn J, Rubin M, Jarosinski P, Gill V, Young RC, et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995;13:165-76.
-
(1995)
J Clin Oncol
, vol.13
, pp. 165-176
-
-
Freifeld, A.G.1
Walsh, T.2
Marshall, D.3
Gress, J.4
Steinberg, S.M.5
Hathorn, J.6
Rubin, M.7
Jarosinski, P.8
Gill, V.9
Young, R.C.10
-
142
-
-
33746632124
-
A randomized, openlabel, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies
-
Bow EJ, Rotstein C, Noskin GA, Laverdiere M, Schwarer AP, Segal BH, Seymour JF, Szer J, Sanche S. A randomized, openlabel, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clin Infect Dis 2006;43:447-59.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 447-459
-
-
Bow, E.J.1
Rotstein, C.2
Noskin, G.A.3
Laverdiere, M.4
Schwarer, A.P.5
Segal, B.H.6
Seymour, J.F.7
Szer, J.8
Sanche, S.9
-
143
-
-
0025123862
-
Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy
-
Johnson MP, Ramphal R. Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis 1990;162:981-3.
-
(1990)
J Infect Dis
, vol.162
, pp. 981-983
-
-
Johnson, M.P.1
Ramphal, R.2
-
144
-
-
0034331491
-
Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial
-
Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial. J Clin Oncol 2000;18:3690-8.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3690-3698
-
-
Feld, R.1
DePauw, B.2
Berman, S.3
Keating, A.4
Ho, W.5
-
145
-
-
0344002724
-
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
-
Vandercam B, Gerain J, Humblet Y, Ferrant A, Wauters G, Moreau M, Longueville J, Symann M, Straetmans N. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients. Ann Hematol 2000;79: 152-7.
-
(2000)
Ann Hematol
, vol.79
, pp. 152-157
-
-
Vandercam, B.1
Gerain, J.2
Humblet, Y.3
Ferrant, A.4
Wauters, G.5
Moreau, M.6
Longueville, J.7
Symann, M.8
Straetmans, N.9
-
147
-
-
34247173928
-
Efficacy and safety of cefepime: a systematic review and meta-analysis
-
Yahav D, Paul M, Fraser A, Sarid N, Leibovici L. Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis 2007;7:338-48.
-
(2007)
Lancet Infect Dis
, vol.7
, pp. 338-348
-
-
Yahav, D.1
Paul, M.2
Fraser, A.3
Sarid, N.4
Leibovici, L.5
-
148
-
-
31544456662
-
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
-
Paul M, Yahav D, Fraser A, Leibovici L. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2006;57:176-89.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 176-189
-
-
Paul, M.1
Yahav, D.2
Fraser, A.3
Leibovici, L.4
-
149
-
-
79959847101
-
Comparative efficacy and safety of cefepime alone versus ceftazidime plus tobramycin in cancer patients with febrile neutropenia
-
Jung HW, Chae JW, Kang MR, Yang JC, Moon CS, Ki HK, Chang HH, Oh WS, Kim K, Peck KR, Lee NY, Song JH. Comparative efficacy and safety of cefepime alone versus ceftazidime plus tobramycin in cancer patients with febrile neutropenia. Infect Chemother 2004;36:341-9.
-
(2004)
Infect Chemother
, vol.36
, pp. 341-349
-
-
Jung, H.W.1
Chae, J.W.2
Kang, M.R.3
Yang, J.C.4
Moon, C.S.5
Ki, H.K.6
Chang, H.H.7
Oh, W.S.8
Kim, K.9
Peck, K.R.10
Lee, N.Y.11
Song, J.H.12
-
150
-
-
79959822403
-
A comparative study of cefepime versus ceftazidime monotherapy as empirical therapy for febrile episodes in neutropenic patients
-
Lee DH, Kim CK, Ko JY, Ma JR, Lee GY, Chon SY, Kim BS, Noh YH. A comparative study of cefepime versus ceftazidime monotherapy as empirical therapy for febrile episodes in neutropenic patients. J Korean Soc chem 2002;20:243-51.
-
(2002)
J Korean Soc chem
, vol.20
, pp. 243-251
-
-
Lee, D.H.1
Kim, C.K.2
Ko, J.Y.3
Ma, J.R.4
Lee, G.Y.5
Chon, S.Y.6
Kim, B.S.7
Noh, Y.H.8
-
151
-
-
0024398113
-
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients
-
Flaherty JP, Waitley D, Edlin B, George D, Arnow P, O'Keefe P, Weinstein RA. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Am J Med 1989; 87:278S-82S.
-
(1989)
Am J Med
, vol.87
-
-
Flaherty, J.P.1
Waitley, D.2
Edlin, B.3
George, D.4
Arnow, P.5
O'Keefe, P.6
Weinstein, R.A.7
-
152
-
-
0028836245
-
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer
-
Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother 1995;39:445-52.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 445-452
-
-
Cometta, A.1
Zinner, S.2
de Bock, R.3
Calandra, T.4
Gaya, H.5
Klastersky, J.6
Langenaeken, J.7
Paesmans, M.8
Viscoli, C.9
Glauser, M.P.10
-
153
-
-
16944363887
-
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group
-
Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Clin Infect Dis 1997;24:41-51.
-
(1997)
Clin Infect Dis
, vol.24
, pp. 41-51
-
-
Cordonnier, C.1
Herbrecht, R.2
Pico, J.L.3
Gardembas, M.4
Delmer, A.5
Delain, M.6
Moreau, P.7
Ladeb, S.8
Nalet, V.9
Rollin, C.10
Gres, J.J.11
-
154
-
-
0037118676
-
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial
-
Peacock JE, Herrington DA, Wade JC, Lazarus HM, Reed MD, Sinclair JW, Haverstock DC, Kowalsky SF, Hurd DD, Cushing DA, Harman CP, Donowitz GR. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. Ann Intern Med 2002;137:77-87.
-
(2002)
Ann Intern Med
, vol.137
, pp. 77-87
-
-
Peacock, J.E.1
Herrington, D.A.2
Wade, J.C.3
Lazarus, H.M.4
Reed, M.D.5
Sinclair, J.W.6
Haverstock, D.C.7
Kowalsky, S.F.8
Hurd, D.D.9
Cushing, D.A.10
Harman, C.P.11
Donowitz, G.R.12
-
155
-
-
0035996098
-
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial
-
Sanz MA, Lopez J, Lahuerta JJ, Rovira M, Batlle M, Perez C, Vazquez L, Julia A, Palau J, Gutierrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. J Antimicrob Chemother 2002;50:79-88.
-
(2002)
J Antimicrob Chemother
, vol.50
, pp. 79-88
-
-
Sanz, M.A.1
Lopez, J.2
Lahuerta, J.J.3
Rovira, M.4
Batlle, M.5
Perez, C.6
Vazquez, L.7
Julia, A.8
Palau, J.9
Gutierrez, M.10
Capote, F.J.11
Ramos, F.12
Benlloch, L.13
Larrea, L.14
Jarque, I.15
-
156
-
-
0032814522
-
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity
-
Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 1999;43:1549-55.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1549-1555
-
-
Rybak, M.J.1
Abate, B.J.2
Kang, S.L.3
Ruffing, M.J.4
Lerner, S.A.5
Drusano, G.L.6
-
157
-
-
34249992661
-
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
-
Torfoss D, Hoiby EA, Tangen JM, Holte H, Bo K, Meyer P, Grottum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaloy S. Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. J Antimicrob Chemother 2007;59:711-7.
-
(2007)
J Antimicrob Chemother
, vol.59
, pp. 711-717
-
-
Torfoss, D.1
Hoiby, E.A.2
Tangen, J.M.3
Holte, H.4
Bo, K.5
Meyer, P.6
Grottum, K.7
Weyde, K.8
Lauritzsen, G.F.9
Sandstad, B.10
Jacobsen, A.B.11
Olsen, H.12
Kvaloy, S.13
-
158
-
-
33646772759
-
Clinical features and risk factors of the septic shock in patients with neutropenic fever
-
Choi SM, Lee DG, Kim MJ, Kim DY, Park YH, Kim YJ, Kim HJ, Lee S, Choi JH, Yoo JH, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Clinical features and risk factors of the septic shock in patients with neutropenic fever. Infect Chemother 2003;35: 370-6.
-
(2003)
Infect Chemother
, vol.35
, pp. 370-376
-
-
Choi, S.M.1
Lee, D.G.2
Kim, M.J.3
Kim, D.Y.4
Park, Y.H.5
Kim, Y.J.6
Kim, H.J.7
Lee, S.8
Choi, J.H.9
Yoo, J.H.10
Kim, D.W.11
Lee, J.W.12
Min, W.S.13
Shin, W.S.14
Kim, C.C.15
-
159
-
-
0034331492
-
Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care
-
Elting LS, Rubenstein EB, Rolston K, Cantor SB, Martin CG, Kurtin D, Rodriguez S, Lam T, Kanesan K, Bodey G. Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care. J Clin Oncol 2000;18:3699-706.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3699-3706
-
-
Elting, L.S.1
Rubenstein, E.B.2
Rolston, K.3
Cantor, S.B.4
Martin, C.G.5
Kurtin, D.6
Rodriguez, S.7
Lam, T.8
Kanesan, K.9
Bodey, G.10
-
160
-
-
39049084813
-
The efficacy and safety of oral ciprofloxacin therapy for low-risk febrite patients with neutropenia during cancer chemotherapy
-
Kim WS, Lee H, Ki HK, Kim CK, Kim SW, Kim S, Peck KR, Kim WS, Youn SS, Lee HK, Kang WK, Park CH, Park KC, Song JH. The efficacy and safety of oral ciprofloxacin therapy for low-risk febrite patients with neutropenia during cancer chemotherapy. J Korean Soc Chem 2000;18:29-38.
-
(2000)
J Korean Soc Chem
, vol.18
, pp. 29-38
-
-
Kim, W.S.1
Lee, H.2
Ki, H.K.3
Kim, C.K.4
Kim, S.W.5
Kim, S.6
Peck, K.R.7
Kim, W.S.8
Youn, S.S.9
Lee, H.K.10
Kang, W.K.11
Park, C.H.12
Park, K.C.13
Song, J.H.14
-
161
-
-
0025883606
-
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer, patients., European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials, Group
-
Anonymous
-
Anonymous. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. J Infect Dis 1991;163:951-8.
-
(1991)
J Infect Dis
, vol.163
, pp. 951-958
-
-
-
162
-
-
0025695106
-
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients
-
Micozzi A, Venditti M, Amadori S, Pulsoni A, Tirindelli C, Martino P. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients. Br J Haematol 1990;76 (Suppl 2):19-23.
-
(1990)
Br J Haematol
, vol.76
, Issue.SUPPL. 2
, pp. 19-23
-
-
Micozzi, A.1
Venditti, M.2
Amadori, S.3
Pulsoni, A.4
Tirindelli, C.5
Martino, P.6
-
163
-
-
20544455903
-
Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a metaanalysis of randomised controlled trials
-
Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA, Falagas ME. Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a metaanalysis of randomised controlled trials. Lancet Infect Dis 2005;5:431-9.
-
(2005)
Lancet Infect Dis
, vol.5
, pp. 431-439
-
-
Vardakas, K.Z.1
Samonis, G.2
Chrysanthopoulou, S.A.3
Bliziotis, I.A.4
Falagas, M.E.5
-
164
-
-
17444419077
-
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
-
Paul M, Borok S, Fraser A, Vidal L, Leibovici L. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2005;55:436-44.
-
(2005)
J Antimicrob Chemother
, vol.55
, pp. 436-444
-
-
Paul, M.1
Borok, S.2
Fraser, A.3
Vidal, L.4
Leibovici, L.5
-
165
-
-
0030858393
-
Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials
-
Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-59.
-
(1997)
Clin Infect Dis
, vol.25
, pp. 247-259
-
-
Elting, L.S.1
Rubenstein, E.B.2
Rolston, K.V.3
Bodey, G.P.4
-
166
-
-
25144497058
-
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients
-
Glasmacher A, von Lilienfeld-Toal M, Schulte S, Hahn C, Schmidt-Wolf IG, Prentice A. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clin Microbiol Infect 2005;11 (Suppl 5):17-23.
-
(2005)
Clin Microbiol Infect
, vol.11
, Issue.SUPPL. 5
, pp. 17-23
-
-
Glasmacher, A.1
von Lilienfeld-Toal, M.2
Schulte, S.3
Hahn, C.4
Schmidt-Wolf, I.G.5
Prentice, A.6
-
167
-
-
4444315311
-
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia
-
Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB, Kim EC, Oh MD, Choe KW. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004;54:489-97.
-
(2004)
J Antimicrob Chemother
, vol.54
, pp. 489-497
-
-
Kim, S.H.1
Park, W.B.2
Lee, K.D.3
Kang, C.I.4
Bang, J.W.5
Kim, H.B.6
Kim, E.C.7
Oh, M.D.8
Choe, K.W.9
-
168
-
-
36148941699
-
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital
-
Uh Y, Hwang GY, Jang IH, Kwon O, Kim HY, Yoon KJ. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital. J Korean Med Sci 2007;22:791-4.
-
(2007)
J Korean Med Sci
, vol.22
, pp. 791-794
-
-
Uh, Y.1
Hwang, G.Y.2
Jang, I.H.3
Kwon, O.4
Kim, H.Y.5
Yoon, K.J.6
-
169
-
-
78651100546
-
Antimicrobial susceptibilities of viridans streptococci isolated from blood cultures during recent period
-
Uh Y, Hwang GY, Jang IH, Yoon KJ, Kim HY. Antimicrobial susceptibilities of viridans streptococci isolated from blood cultures during recent period. J Lab Med Qual Assur 2002; 24:225-30.
-
(2002)
J Lab Med Qual Assur
, vol.24
, pp. 225-230
-
-
Uh, Y.1
Hwang, G.Y.2
Jang, I.H.3
Yoon, K.J.4
Kim, H.Y.5
-
170
-
-
0042160270
-
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy
-
Cometta A, Kern WV, De Bock R, Paesmans M, Vandenbergh M, Crokaert F, Engelhard D, Marchetti O, Akan H, Skoutelis A, Korten V, Vandercam M, Gaya H, Padmos A, Klastersky J, Zinner S, Glauser MP, Calandra T, Viscoli C. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis 2003;37:382-9.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 382-389
-
-
Cometta, A.1
Kern, W.V.2
De Bock, R.3
Paesmans, M.4
Vandenbergh, M.5
Crokaert, F.6
Engelhard, D.7
Marchetti, O.8
Akan, H.9
Skoutelis, A.10
Korten, V.11
Vandercam, M.12
Gaya, H.13
Padmos, A.14
Klastersky, J.15
Zinner, S.16
Glauser, M.P.17
Calandra, T.18
Viscoli, C.19
-
171
-
-
0034129459
-
A prospective, randomized, double-blinded, placebocontrolled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy
-
Erjavec Z, de Vries-Hospers HG, Laseur M, Halie RM, Daenen S. A prospective, randomized, double-blinded, placebocontrolled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. J Antimicrob Chemother 2000;45:843-9.
-
(2000)
J Antimicrob Chemother
, vol.45
, pp. 843-849
-
-
Erjavec, Z.1
de Vries-Hospers, H.G.2
Laseur, M.3
Halie, R.M.4
Daenen, S.5
-
172
-
-
70349510433
-
Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis
-
Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 2009;53: 4069-79.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 4069-4079
-
-
Svetitsky, S.1
Leibovici, L.2
Paul, M.3
-
173
-
-
39449112495
-
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
-
Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008;46:193-200.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 193-200
-
-
Soriano, A.1
Marco, F.2
Martinez, J.A.3
Pisos, E.4
Almela, M.5
Dimova, V.P.6
Alamo, D.7
Ortega, M.8
Lopez, J.9
Mensa, J.10
-
174
-
-
53249113145
-
Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis
-
Brink AJ, Richards GA, Cummins RR, Lambson J. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis. Int J Antimicrob Agents 2008;32:455-8.
-
(2008)
Int J Antimicrob Agents
, vol.32
, pp. 455-458
-
-
Brink, A.J.1
Richards, G.A.2
Cummins, R.R.3
Lambson, J.4
-
175
-
-
0021236431
-
Hickman catheter infections in patients with malignancies
-
Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 1984;63:189-200.
-
(1984)
Medicine (Baltimore)
, vol.63
, pp. 189-200
-
-
Press, O.W.1
Ramsey, P.G.2
Larson, E.B.3
Fefer, A.4
Hickman, R.O.5
-
176
-
-
0025347730
-
A conservative procedure for the diagnosis of catheterrelated infections
-
Cercenado E, Ena J, Rodriguez-Creixems M, Romero I, Bouza E. A conservative procedure for the diagnosis of catheterrelated infections. Arch Intern Med 1990;150:1417-20.
-
(1990)
Arch Intern Med
, vol.150
, pp. 1417-1420
-
-
Cercenado, E.1
Ena, J.2
Rodriguez-Creixems, M.3
Romero, I.4
Bouza, E.5
-
177
-
-
0040562485
-
Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures
-
Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, Laplanche A, Brun-Buisson C, Tancrede C. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999;354:1071-7.
-
(1999)
Lancet
, vol.354
, pp. 1071-1077
-
-
Blot, F.1
Nitenberg, G.2
Chachaty, E.3
Raynard, B.4
Germann, N.5
Antoun, S.6
Laplanche, A.7
Brun-Buisson, C.8
Tancrede, C.9
-
178
-
-
0347716451
-
Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections
-
Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004;140:18-25.
-
(2004)
Ann Intern Med
, vol.140
, pp. 18-25
-
-
Raad, I.1
Hanna, H.A.2
Alakech, B.3
Chatzinikolaou, I.4
Johnson, M.M.5
Tarrand, J.6
-
179
-
-
5444232859
-
Detection of catheter-related bloodstream infections by the differentialtime-to-positivity method and gram stain-acridine orange leukocyte cytospin test in neutropenic patients after hematopoietic stem cell transplantation
-
Krause R, Auner HW, Gorkiewicz G, Wolfler A, Daxboeck F, Linkesch W, Krejs GJ, Wenisch C, Reisinger EC. Detection of catheter-related bloodstream infections by the differentialtime-to-positivity method and gram stain-acridine orange leukocyte cytospin test in neutropenic patients after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42:4835-7.
-
(2004)
J Clin Microbiol
, vol.42
, pp. 4835-4837
-
-
Krause, R.1
Auner, H.W.2
Gorkiewicz, G.3
Wolfler, A.4
Daxboeck, F.5
Linkesch, W.6
Krejs, G.J.7
Wenisch, C.8
Reisinger, E.C.9
-
180
-
-
20044374670
-
Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients
-
Abdelkefi A, Achour W, Ben Othman T, Torjman L, Ladeb S, Lakhal A, Hsairi M, Kammoun L, Ben Hassen A, Ben Abdeladhim A. Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005;35:397-401.
-
(2005)
Bone Marrow Transplant
, vol.35
, pp. 397-401
-
-
Abdelkefi, A.1
Achour, W.2
Ben Othman, T.3
Torjman, L.4
Ladeb, S.5
Lakhal, A.6
Hsairi, M.7
Kammoun, L.8
Ben Hassen, A.9
Ben Abdeladhim, A.10
-
181
-
-
0031975454
-
Earlier positivity of central-venousversus peripheral-blood cultures is highly predictive of ca theter-related sepsis
-
Blot F, Schmidt E, Nitenberg G, Tancrede C, Leclercq B, Laplanche A, Andremont A. Earlier positivity of central-venousversus peripheral-blood cultures is highly predictive of ca theter-related sepsis. J Clin Microbiol 1998;36:105-9.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 105-109
-
-
Blot, F.1
Schmidt, E.2
Nitenberg, G.3
Tancrede, C.4
Leclercq, B.5
Laplanche, A.6
Andremont, A.7
-
182
-
-
66949140382
-
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America
-
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad, II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1-45
-
-
Mermel, L.A.1
Allon, M.2
Bouza, E.3
Craven, D.E.4
Flynn, P.5
O'Grady, N.P.6
Raad, I.I.7
Rijnders, B.J.8
Sherertz, R.J.9
Warren, D.K.10
-
183
-
-
58749115917
-
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study
-
Wilcox MH, Tack KJ, Bouza E, Herr DL, Ruf BR, Ijzerman MM, Croos-Dabrera RV, Kunkel MJ, Knirsch C. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis 2009;48:203-12.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 203-212
-
-
Wilcox, M.H.1
Tack, K.J.2
Bouza, E.3
Herr, D.L.4
Ruf, B.R.5
Ijzerman, M.M.6
Croos-Dabrera, R.V.7
Kunkel, M.J.8
Knirsch, C.9
-
184
-
-
0347951402
-
Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia
-
Kim SH, Kang CI, Kim HB, Youn SS, Oh MD, Kim EC, Park SY, Kim BK, Choe KW. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2003; 24:897-904.
-
(2003)
Infect Control Hosp Epidemiol
, vol.24
, pp. 897-904
-
-
Kim, S.H.1
Kang, C.I.2
Kim, H.B.3
Youn, S.S.4
Oh, M.D.5
Kim, E.C.6
Park, S.Y.7
Kim, B.K.8
Choe, K.W.9
-
185
-
-
0025073491
-
Staphylococcus aureus bacteremia in patients with Hickman catheters
-
Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990;89:137-41.
-
(1990)
Am J Med
, vol.89
, pp. 137-141
-
-
Dugdale, D.C.1
Ramsey, P.G.2
-
186
-
-
0019946004
-
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
-
Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72: 101-11.
-
(1982)
Am J Med
, vol.72
, pp. 101-111
-
-
Pizzo, P.A.1
Robichaud, K.J.2
Gill, F.A.3
Witebsky, F.G.4
-
187
-
-
0024371959
-
Empiric antifungal therapy in febrile granulocytopenic, patients., EORTC., International Antimicrobial Therapy Cooperative, Group
-
Anonymous
-
Anonymous. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group. Am J Med 1989;86:668-72.
-
(1989)
Am J Med
, vol.86
, pp. 668-672
-
-
-
188
-
-
0842307151
-
Empirical antifungal therapy
-
Klastersky J. Empirical antifungal therapy. Int J Antimicrob Agents 2004;23:105-12.
-
(2004)
Int J Antimicrob Agents
, vol.23
, pp. 105-112
-
-
Klastersky, J.1
-
189
-
-
3242782339
-
Empirical antifungal therapy in treating febrile neutropenic patients
-
Wingard JR. Empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis 2004;39 (Suppl 1):S38-43.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.SUPPL. 1
-
-
Wingard, J.R.1
-
190
-
-
54849140300
-
Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis
-
Goldberg E, Gafter-Gvili A, Robenshtok E, Leibovici L, Paul M. Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis. Eur J Cancer 2008;44:2192-203.
-
(2008)
Eur J Cancer
, vol.44
, pp. 2192-2203
-
-
Goldberg, E.1
Gafter-Gvili, A.2
Robenshtok, E.3
Leibovici, L.4
Paul, M.5
-
191
-
-
53349171951
-
Factors associated with overall and attributable mortality in invasive aspergillosis
-
Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008;47:1176-84.
-
(2008)
Clin Infect Dis
, vol.47
, pp. 1176-1184
-
-
Nivoix, Y.1
Velten, M.2
Letscher-Bru, V.3
Moghaddam, A.4
Natarajan-Ame, S.5
Fohrer, C.6
Lioure, B.7
Bilger, K.8
Lutun, P.9
Marcellin, L.10
Launoy, A.11
Freys, G.12
Bergerat, J.P.13
Herbrecht, R.14
-
192
-
-
37949005246
-
Analysis of invasive fungal infection after hematopoietic stem cell transplantation or chemotherapy in patients with hematologic diseases
-
Yoo JH, Choi JH, Lee DG, Choi S, Shin WS, Kim CC. Analysis of invasive fungal infection after hematopoietic stem cell transplantation or chemotherapy in patients with hematologic diseases. Infect Chemother 2004;36:40-5.
-
(2004)
Infect Chemother
, vol.36
, pp. 40-45
-
-
Yoo, J.H.1
Choi, J.H.2
Lee, D.G.3
Choi, S.4
Shin, W.S.5
Kim, C.C.6
-
193
-
-
39449095735
-
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
-
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 327-360
-
-
Walsh, T.J.1
Anaissie, E.J.2
Denning, D.W.3
Herbrecht, R.4
Kontoyiannis, D.P.5
Marr, K.A.6
Morrison, V.A.7
Segal, B.H.8
Steinbach, W.J.9
Stevens, D.A.10
van Burik, J.A.11
Wingard, J.R.12
Patterson, T.F.13
-
194
-
-
60549098868
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
-
Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr., Calandra TF, Edwards JE, Jr., Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-35.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 503-535
-
-
Pappas, P.G.1
Kauffman, C.A.2
Andes, D.3
Benjamin Jr., D.K.4
Calandra, T.F.5
Edwards Jr., J.E.6
Filler, S.G.7
Fisher, J.F.8
Kullberg, B.J.9
Ostrosky-Zeichner, L.10
Reboli, A.C.11
Rex, J.H.12
Walsh, T.J.13
Sobel, J.D.14
-
195
-
-
70249140598
-
Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation
-
Michallet M, Ito JI. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation. J Clin Oncol 2009;27: 3398-409.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3398-3409
-
-
Michallet, M.1
Ito, J.I.2
-
196
-
-
36248941920
-
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea
-
Lee JS, Shin JH, Lee K, Kim MN, Shin BM, Uh Y, Lee WG, Lee HS, Chang CL, Kim SH, Shin MG, Suh SP, Ryang DW. Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea. Yonsei Med J 2007;48:779-86.
-
(2007)
Yonsei Med J
, vol.48
, pp. 779-786
-
-
Lee, J.S.1
Shin, J.H.2
Lee, K.3
Kim, M.N.4
Shin, B.M.5
Uh, Y.6
Lee, W.G.7
Lee, H.S.8
Chang, C.L.9
Kim, S.H.10
Shin, M.G.11
Suh, S.P.12
Ryang, D.W.13
-
197
-
-
34147144919
-
Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia
-
Bal AM, Gould IM. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia. Int J Antimicrob Agents 2007;29:501-9.
-
(2007)
Int J Antimicrob Agents
, vol.29
, pp. 501-509
-
-
Bal, A.M.1
Gould, I.M.2
-
198
-
-
0033545538
-
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group
-
Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999;340:764-71.
-
(1999)
N Engl J Med
, vol.340
, pp. 764-771
-
-
Walsh, T.J.1
Finberg, R.W.2
Arndt, C.3
Hiemenz, J.4
Schwartz, C.5
Bodensteiner, D.6
Pappas, P.7
Seibel, N.8
Greenberg, R.N.9
Dummer, S.10
Schuster, M.11
Holcenberg, J.S.12
-
199
-
-
0037165259
-
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
-
Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdiere M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346:225-34.
-
(2002)
N Engl J Med
, vol.346
, pp. 225-234
-
-
Walsh, T.J.1
Pappas, P.2
Winston, D.J.3
Lazarus, H.M.4
Petersen, F.5
Raffalli, J.6
Yanovich, S.7
Stiff, P.8
Greenberg, R.9
Donowitz, G.10
Schuster, M.11
Reboli, A.12
Wingard, J.13
Arndt, C.14
Reinhardt, J.15
Hadley, S.16
Finberg, R.17
Laverdiere, M.18
Perfect, J.19
Garber, G.20
Fioritoni, G.21
Anaissie, E.22
Lee, J.23
more..
-
200
-
-
4644346490
-
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
-
Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004;351: 1391-402.
-
(2004)
N Engl J Med
, vol.351
, pp. 1391-1402
-
-
Walsh, T.J.1
Teppler, H.2
Donowitz, G.R.3
Maertens, J.A.4
Baden, L.R.5
Dmoszynska, A.6
Cornely, O.A.7
Bourque, M.R.8
Lupinacci, R.J.9
Sable, C.A.10
dePauw, B.E.11
-
201
-
-
70349932352
-
Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
-
Girmenia C, Barosi G, Aversa F, Bacigalupo A, Barbui T, Baronciani D, Bosi A, Candoni A, Locasciulli A, Locatelli F, Menichetti F, Musso M, Viscoli C, Rambaldi A. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 2009;49:1226-36.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1226-1236
-
-
Girmenia, C.1
Barosi, G.2
Aversa, F.3
Bacigalupo, A.4
Barbui, T.5
Baronciani, D.6
Bosi, A.7
Candoni, A.8
Locasciulli, A.9
Locatelli, F.10
Menichetti, F.11
Musso, M.12
Viscoli, C.13
Rambaldi, A.14
-
202
-
-
9844239388
-
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
-
Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 1997;98:711-8.
-
(1997)
Br J Haematol
, vol.98
, pp. 711-718
-
-
Prentice, H.G.1
Hann, I.M.2
Herbrecht, R.3
Aoun, M.4
Kvaloy, S.5
Catovsky, D.6
Pinkerton, C.R.7
Schey, S.A.8
Jacobs, F.9
Oakhill, A.10
Stevens, R.F.11
Darbyshire, P.J.12
Gibson, B.E.13
-
203
-
-
0035909054
-
De Beule K. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial
-
Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Ann Intern Med 2001;135:412-22.
-
(2001)
Ann Intern Med
, vol.135
, pp. 412-422
-
-
Boogaerts, M.1
Winston, D.J.2
Bow, E.J.3
Garber, G.4
Reboli, A.C.5
Schwarer, A.P.6
Novitzky, N.7
Boehme, A.8
Chwetzoff, E.9
-
204
-
-
34948817348
-
Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever
-
Park SH, Choi SM, Lee DG, Choi JH, Yoo JH, Min WS, Shin WS. Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever. Korean J Intern Med 2006;21: 165-72.
-
(2006)
Korean J Intern Med
, vol.21
, pp. 165-172
-
-
Park, S.H.1
Choi, S.M.2
Lee, D.G.3
Choi, J.H.4
Yoo, J.H.5
Min, W.S.6
Shin, W.S.7
-
205
-
-
33947602411
-
Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy
-
Schuler U, Bammer S, Aulitzky WE, Binder C, Bohme A, Egerer G, Sandherr M, Schwerdtfeger R, Silling G, Wandt H, Glasmacher A, Ehninger G. Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy. Onkologie 2007;30:185-91.
-
(2007)
Onkologie
, vol.30
, pp. 185-191
-
-
Schuler, U.1
Bammer, S.2
Aulitzky, W.E.3
Binder, C.4
Bohme, A.5
Egerer, G.6
Sandherr, M.7
Schwerdtfeger, R.8
Silling, G.9
Wandt, H.10
Glasmacher, A.11
Ehninger, G.12
-
206
-
-
65449123094
-
Aspergillosis
-
Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84.
-
(2009)
N Engl J Med
, vol.360
, pp. 1870-1884
-
-
Segal, B.H.1
-
207
-
-
0033972985
-
A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
-
Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med 2000;108:282-9.
-
(2000)
Am J Med
, vol.108
, pp. 282-289
-
-
Winston, D.J.1
Hathorn, J.W.2
Schuster, M.G.3
Schiller, G.J.4
Territo, M.C.5
-
208
-
-
46249126149
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
-
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1813-1821
-
-
De Pauw, B.1
Walsh, T.J.2
Donnelly, J.P.3
Stevens, D.A.4
Edwards, J.E.5
Calandra, T.6
Pappas, P.G.7
Maertens, J.8
Lortholary, O.9
Kauffman, C.A.10
Denning, D.W.11
Patterson, T.F.12
Maschmeyer, G.13
Bille, J.14
Dismukes, W.E.15
Herbrecht, R.16
Hope, W.W.17
Kibbler, C.C.18
Kullberg, B.J.19
Marr, K.A.20
Munoz, P.21
Odds, F.C.22
Perfect, J.R.23
Restrepo, A.24
Ruhnke, M.25
Segal, B.H.26
Sobel, J.D.27
Sorrell, T.C.28
Viscoli, C.29
Wingard, J.R.30
Zaoutis, T.31
Bennett, J.E.32
more..
-
209
-
-
67651114113
-
Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges
-
Ben-Ami R, Lewis RE, Kontoyiannis DP. Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis 2009;22:376-84.
-
(2009)
Curr Opin Infect Dis
, vol.22
, pp. 376-384
-
-
Ben-Ami, R.1
Lewis, R.E.2
Kontoyiannis, D.P.3
-
210
-
-
27444447144
-
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study
-
Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005;41:1242-50.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1242-1250
-
-
Maertens, J.1
Theunissen, K.2
Verhoef, G.3
Verschakelen, J.4
Lagrou, K.5
Verbeken, E.6
Wilmer, A.7
Verhaegen, J.8
Boogaerts, M.9
Van Eldere, J.10
-
211
-
-
63649156819
-
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial
-
Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhedin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis 2009;48:1042-51.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1042-1051
-
-
Cordonnier, C.1
Pautas, C.2
Maury, S.3
Vekhoff, A.4
Farhat, H.5
Suarez, F.6
Dhedin, N.7
Isnard, F.8
Ades, L.9
Kuhnowski, F.10
Foulet, F.11
Kuentz, M.12
Maison, P.13
Bretagne, S.14
Schwarzinger, M.15
-
212
-
-
13444274289
-
Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases
-
Yoo JH, Choi JH, Choi SM, Lee DG, Shin WS, Min WS, Kim CC. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases. Clin Infect Dis 2005;40:392-8.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 392-398
-
-
Yoo, J.H.1
Choi, J.H.2
Choi, S.M.3
Lee, D.G.4
Shin, W.S.5
Min, W.S.6
Kim, C.C.7
-
214
-
-
78649633948
-
Diagnostic usefulness of galactomannan assay for invasive aspergillosis
-
Song KH, Lee S, Jang HC, Jeon JH, Park WB, Park KU, Park SW, Oh MD, Choe KW. Diagnostic usefulness of galactomannan assay for invasive aspergillosis. Infect Chemother 2009;41:82-9.
-
(2009)
Infect Chemother
, vol.41
, pp. 82-89
-
-
Song, K.H.1
Lee, S.2
Jang, H.C.3
Jeon, J.H.4
Park, W.B.5
Park, K.U.6
Park, S.W.7
Oh, M.D.8
Choe, K.W.9
-
216
-
-
33646464211
-
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis
-
Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006;42:1417-27.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 1417-1427
-
-
Pfeiffer, C.D.1
Fine, J.P.2
Safdar, N.3
-
217
-
-
58849098756
-
Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients
-
Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009;47:129-33.
-
(2009)
J Clin Microbiol
, vol.47
, pp. 129-133
-
-
Hachem, R.Y.1
Kontoyiannis, D.P.2
Chemaly, R.F.3
Jiang, Y.4
Reitzel, R.5
Raad, I.6
-
218
-
-
34548565614
-
Comparison of the real-time nucleic acid sequence-based amplification (RTi-NASBA) with conventional NASBA, and galactomannan assay for the diagnosis of invasive aspergillosis
-
Yoo JH, Choi SM, Lee DG, Park SH, Choi JH, Kwon EY, Shin WS. Comparison of the real-time nucleic acid sequence-based amplification (RTi-NASBA) with conventional NASBA, and galactomannan assay for the diagnosis of invasive aspergillosis. J Korean Med Sci 2007;22:672-6.
-
(2007)
J Korean Med Sci
, vol.22
, pp. 672-676
-
-
Yoo, J.H.1
Choi, S.M.2
Lee, D.G.3
Park, S.H.4
Choi, J.H.5
Kwon, E.Y.6
Shin, W.S.7
|